How is trichomoniasis diagnosed in a male patient?

Diagnosis of Trichomoniasis in Males

In male patients, trichomoniasis should be diagnosed using nucleic acid amplification testing (NAAT) on either first-void urine or urethral swab specimens, as this method has superior sensitivity compared to traditional wet mount microscopy or culture. 1, 2

Diagnostic Testing Approach

Preferred Testing Method

• NAAT (e.g., transcription-mediated amplification) is the most sensitive diagnostic method for detecting T. vaginalis in men, significantly outperforming wet mount microscopy and culture 1, 2, 3
• First-void urine specimens are the preferred sample type for male testing, as they are non-invasive and have comparable sensitivity to urethral swabs 3
• Urethral swabs can also be used and may be collected during routine STI screening 1

Alternative Testing Methods (Less Sensitive)

• Culture remains the most sensitive commercially available non-NAAT method, though it is still inferior to molecular testing 1
• Wet mount microscopy of urethral discharge or urine sediment has very poor sensitivity (approximately 60-70% in women, even lower in men) and should not be relied upon 1, 4
• Nested PCR has shown excellent sensitivity in research settings and may detect cases missed by culture and direct microscopy 4, 5

Clinical Context

Symptom Presentation

• Most infected men (approximately 70-80%) are asymptomatic, making clinical diagnosis unreliable 1, 2
• When symptomatic, men typically present with non-gonococcal urethritis (NGU), though some may have urethral discharge, dysuria, or urethral irritation 1
• Urine cytology may occasionally identify Trichomonas organisms, particularly in older men presenting with hematuria or lower urinary tract symptoms 6

Testing Indications

• Male sexual partners of women diagnosed with trichomoniasis should be tested, as 71.7% will have concordant infection 2
• Consider testing in men presenting with NGU or persistent urethritis 1
• Screen men in high-prevalence STI communities, particularly African American men who have significantly higher infection rates 3, 7
• Testing may be considered in infertility evaluations, though the relationship remains incompletely understood 5

Important Caveats

Laboratory Considerations

• NAAT for T. vaginalis may not be FDA-approved for male specimens, but laboratories meeting CLIA requirements that have validated their test performance on male specimens may perform this testing 1
• Commercial laboratories often offer PCR testing even without FDA approval for male specimens 1
• Urine samples should be first-void specimens for optimal organism detection 3

Partner Management

• Given the high concordance rate (>70%) in male partners of infected women, empiric treatment without testing is reasonable when follow-up is uncertain 1, 2
• The CDC recommends empiric treatment for sexual assault survivors due to poor follow-up compliance 1